This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Freeport's Earnings Surpass Estimates in Q4, Revenues Miss
by Zacks Equity Research
Lower copper and gold sales in the fourth quarter adversely impact FCX's top line.
DuPont MOLYKOTE HP-300 Grease Meets Hydrogen Purity Standards
by Zacks Equity Research
DD's MOLYKOTE HP-300 successfully met hydrogen purity standards by conducting tests developed in collaboration with HyCentA Research GmbH.
Steel Dynamics' Q4 Earnings Surpass Estimates, Sales Miss
by Zacks Equity Research
STLD believes that the market conditions are in place to support rising demand across its operational platforms in 2025.
4 High Earnings Yield Value Stocks to Buy as Trump Resumes Presidency
by Rimmi Singhi
Unlock your portfolio value with high earnings yield value stocks like HRMY, NGVT, GPOR and PBI.
Olin Inks Agreement to Acquire AMMO's Ammunition Assets for $75M
by Zacks Equity Research
OLN is set to acquire AMMO's small caliber ammunition manufacturing assets for $75 million to enhance participation across high-margin specialty calibers.
FSI Inks New Contract for Food-Grade Manufacturing Business
by Zacks Equity Research
Flexible Solutions signs a new contract to manufacture food-grade products for a U.S.-based company while aiming to boost revenues.
Best Value Stocks to Buy for January 21st
by Zacks Equity Research
NGVT, ICL and ADNT made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 21, 2025.
NGVT to Evaluate Strategic Alternatives for Industrial Specialties
by Zacks Equity Research
Ingevity plans to review strategic alternatives for the Performance Chemicals Industrial Specialties product line to increase its shareholder value.
Ingevity Stock Up 23% in 3 Months: What's Driving the Rally?
by Zacks Equity Research
NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.
BASF SE Divests Food and Health Performance Ingredients Unit
by Zacks Equity Research
BASFY's divestment to LDC supports its strategic portfolio optimization and will help it focus on its core businesses in Nutrition & Health.
Westlake's Unit Announces Investment in Universal Matter
by Zacks Equity Research
The investment by WLK is driven by its continuous efforts to develop a sustainable future.
Here's Why You Should Retain Eastman Chemical Stock in Your Portfolio
by Zacks Equity Research
EMN benefits from its innovation-driven growth strategy and cost-management actions amid demand headwinds in certain markets.
Dow and Innventure to Partner on Waste-to-Value Platform
by Zacks Equity Research
Refinity, Innventure's subsidiary, will work with DOW to scale and commercialize cost-effective waste-to-value technologies, aimed at converting mixed waste.
Is Ingevity (NGVT) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CF Industries' Stock Pops 18% in 6 Months: What's Driving the Rally?
by Zacks Equity Research
CF benefits from higher nitrogen fertilizer demand in major markets, an uptick in nitrogen prices and lower natural gas costs.
Agnico Eagle Mines Inks Deal to Buy O3 Mining in Friendly Transaction
by Zacks Equity Research
The offer of AEM is worth approximately $204 million on a fully diluted in-the-money basis.
Steel Dynamics Expects Lower Q4 Earnings Amid Pricing Pressures
by Zacks Equity Research
Earnings from STLD's steel operations are likely to be significantly lower in the fourth quarter of 2024
Here's Why You Should Hold Onto DuPont's Stock for Now
by Zacks Equity Research
While DD faces headwinds from soft demand, it gains on its focus on growth through innovation and acquisition as well as productivity actions.
RIO to Build Demonstration Plant for Gallium Extraction in Canada
by Zacks Equity Research
Rio Tinto intends to develop a demonstration plant in Canada that can produce up to 3.5 tons of gallium per year.
Rio Tinto Set to Invest $2.5B for Rincon Project in Argentina
by Zacks Equity Research
RIO will move forward with its first commercial-scale lithium operation, the Rincon project, with a $2.5-billion investment.
Here's Why You Should Add Ingevity Stock to Your Portfolio
by Zacks Equity Research
NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions.
Zacks Industry Outlook Axalta Coating Systems, Ingevity and AdvanSix
by Zacks Equity Research
Axalta Coating Systems, Ingevity and AdvanSix have been highlighted in this Industry Outlook article.
3 Chemical Specialty Stocks to Watch Amid Industry Challenges
by Anindya Barman
Soft end-market demand dampens the prospects of the Zacks Chemicals Specialty industry. AXTA, NGVT and ASIX are set to gain from strategic actions to navigate the ongoing challenges.
UEC Acquires Rio Tinto's Sweetwater Plant & Wyoming Uranium Assets
by Zacks Equity Research
Uranium Energy buys Rio Tinto's Wyoming assets, including the Sweetwater plant and uranium mining projects with 175 million pounds of historic resources.
Here's What Makes DuPont Stock a Solid Choice Right Now
by Zacks Equity Research
DD gains on its focus on growth through innovation and acquisition as well as productivity improvement actions.